XML 21 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:    
Net income (loss) $ 10,347 $ (11,553)
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:    
Depreciation and amortization expense 5,141 4,715
Deferred federal income taxes (1,844) (1,575)
Investment losses, net 10,195 205
Share-based payments expense 152 149
Change in ceded unearned premiums (20,708) (30,841)
Change in premiums receivable (15,405) (14,658)
Change in accounts receivable (106) 756
Change in deferred policy acquisition costs 1,711 3,191
Change in unpaid losses and loss adjustment expenses 147 45,533
Change in unearned premiums 21,419 35,388
Change in reinsurance recoverable (69,101) (35,107)
Change in reinsurance balances payable 14,841 5,999
Change in current federal income tax (recoverable)/payable 7,536 (3,581)
Change in all other liabilities (267) 3,091
Change in all other assets 3,007 5,487
Net cash (used in) provided by operating activities (32,935) 7,199
Cash flows from investing activities:    
Purchases of property and equipment (2,101) (2,705)
Purchases of investment securities (222,642) (305,930)
Maturities, sales and redemptions of investment securities 232,081 287,187
Net cash provided by (used in) investing activities 7,338 (21,448)
Cash flows from financing activities:    
Proceeds from exercise of employee stock options 242 231
Purchase of treasury shares (1,807) (5,308)
Net cash used in financing activities (1,565) (5,077)
Decrease in cash and cash equivalents and restricted cash (27,162) (19,326)
Cash and cash equivalents and restricted cash at beginning of year 67,633 86,959
Cash and cash equivalents and restricted cash at end of year $ 40,471 $ 67,633